Quit smoking and control your indoor air quality. Exposure to smoke, dust, fumes, vapors and chemicals can worsen your COPD.
Mike Liddiard is a patient representative living with COPD and contributed to the Change that can’t wait: Reducing the human and economic burden of COPD in Australia report by the health advisory firm ...
The news on vaccines was not so good, as declining sales of shingles shot Shingrix in the US and China pegged back growth to ...
SGMC Health recently launched a Lung Nodule Clinic, a specialized center dedicated to the timely evaluation and treatment of ...
GSK’s antibody-drug conjugate strategy may be making more headlines recently, but the British pharma hasn’t forgotten about ...
Anti-IL5 therapy significantly reduces moderate and severe exacerbations in asthma and COPD, preventing major ...
Providence Holy Cross Medical Center is the first Providence hospital in the San Fernando Valley to offer a minimally ...
The Chosun Ilbo on MSN
Jaksade Approved: First New Pulmonary Fibrosis Drug in a Decade
First New Pulmonary Fibrosis Drug in a Decade Clinical trials show 38% slower lung function decline; Boehringer Ingelheim calls it a breakthrough ...
GSK is shelling out $85 million up front, and possibly $745 million overall, for an RNA-based therapy it sees helping a ...
Brensocatib was associated with decreased exacerbation rates in patients with non-CF bronchiectasis, even in those with ...
Lung Association Steps Up with $22 Million in Research Funding as Federal Support for Science Wavers
Today, the American Lung Association Research Institute announced it has invested $22 million in new research grants, clinical research and strategic partnerships to advance the understanding, ...
An anti-inflammation injectable drug can reduce mucus buildup and improve breathing among asthma patients, a new clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results